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The issue of  labeling foods containing genetically engineered (GE) ingredients 
is central to the controversy over the development of  GE plants and animals 
for human consumption. Currently, the only way for Americans to know 
whether a food contains GE ingredients is to look for the “certified organic” 
label; if  an ingredient is labeled as “organic,” it has not been genetically 
engineered. Americans routinely eat GE corn, soybeans, and other GE plants 
in products that don’t have the “organic” label, but only recently has a food 
animal been developed using gene splicing technology.  The AquAdvantage 
salmon contains genetic material from two other species, the Chinook salmon 
(Oncorhynchus tshawytscha), a Pacific Ocean species, and a species of  eel known 
as the ocean pout (Zoarces americanus), growing twice as fast as its nontransgenic 
counterpart (See Fig. 1).  As part of  its approval process for this new food, the 
Food & Drug Administration (FDA) held an electronic public commenting 
period to find out whether Americans thought the AquAdvantage salmon 
should be labeled as a GE food.  
 
Objective 
We conducted this study to find out what Americans were saying about this 
new fish. We also wanted to assess the extent to which the public understands 
proposed regulations and influences the FDA’s decision making. What are the 
public’s concerns regarding the regulation of  genetically modified animals used 
in consumer products regulated by the FDA? What is the nature and extent of  
their influence in the FDA’s presumably more democratic electronic 
rulemaking process? 
 
Methods 
Reviewed background literature on public’s attitudes toward GE food 
labeling 
Examined FDA Docket on Regulations.gov, the online portal for citizen 
access to proposed federal agency regulations, containing more than 400 
items 
Each researcher separately identified categories of  submissions, coding each 
submission as a distinct “case” with a specific “attribute” 
Used NVivo qualitative content analysis software to find common themes 
and patterns and to code the “cases” 
Coded cases focusing on three “categories of  concern”: social, economic, 
and cultural (Lassen & Jamison, 2006) 
Combined two separate sets of  coding to compare and corroborate results 
 
 
Figure 1. The AquAdvantage salmon versus nontransgenic farm salmon. 
Source: AquaBounty Technologies 
 
Results 
 4% of  the comments addressed the issue of  labeling the fish as GE and the public’s 
“right to know” 
 “The people of  the USA have a right to know what they are buying and eating.”  
 –Case 303 
 
 11% of  the comments discussed how AquAdvantage salmon related to other 
biotechnology risks 
 “We either learn from our previous GM follies or we perish.” –Case 163 
 “The effects from things that we thought were harmless years ago are starting to 
come into full force. Be it the Rbst hormone, the bps in plastics, the depleting of  our 
ozone which could have been intervened upon long ago or what we are dealing with 
now, the results of  over fishing.” –Case 265 
 
 35% of  the comments discussed human and environmental safety issues 
 “There are too many documented health risks and or open questions surrounding 
genetically modified foods.” –Case 50 
 “What I would like, in plain English, is a simple reassurance that FDA will not allow 
unlabeled modified food that contain foreign proteins, unless FDA is sure that those 
inserted proteins (or new proteins created) are absolutely safe from an allergy 
perspective for everybody….” –Case 377.1 
 “These fish are a threat to the marine wildlife, and could very well displace natural 
salmon.” –Case 75 
 “No long term studies have been done that will prove or disprove this creature will 
not destroy the ecosystem.” –Case 56 
Conclusion 
Our results show that although the electronic commenting period was created to 
discuss the issue of  labeling GE salmon, the public only addressed this issue 4% of  
the time. It seemed that the public cared most about how GE salmon could affect 
human health and the environment, as well as how the salmon might relate to 
previous biotechnology risks. In other words, many Americans appear to want GE 
foods eradicated altogether. Those who did comment on the labeling issue believed it 
was necessary for the public to be knowledgeable about eating “non-organic” foods. 
These findings contribute to research on risk perception and the public 
understanding of  science. We suggest that the public might not fully understand the 
regulations proposed by the FDA, such as the application of  the “substantial 
equivalence” concept, and that some Americans are not educated on the subject of  
GE foods.  
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“Attribute” “Case” 
Academic Duke Univ. Medical Center; Univ. of Minnesota 
Advocacy Group Center for Food Safety; WeAreChangeOmaha 
Biotech Company AquaBounty Technologies 
Canadian Media Quantum 
Citizen Focus on political rights and freedoms 
Consumer Focus on exerting power over the market and how they 
spend their money as individuals 
FDA Employees of FDA 
Government 
Organization 
State of Alaska; The Assembly State of New York Albany 
Health Care 
Professional 
RN; Dietician 
Industry 
Organization 
American Salmon Company; National Fisheries Institute 
Professional 
Association 
Chef’s Collaborative;  
American Association of Drugless Practitioners 
Small Business Park Lake Health & Wellness; 
Healthy Living & Wellness, LLC 
Figure 6: Stakeholder Types Examples 
